Antivirals and neutralising Monoclonal Antibodies (nMABs) for COVID-19
20.07.2022
Please note: Due to concerns over the efficacy of sotrovimab against the current circulating Omicron variants of SARS-CoV-2 (BA.2 and others), sotrovimab is not currently being offered routinely. Please discuss any individual patient requirements with one of the Infectious Diseases consultants.